One of the most studied mechanism driving tumor immune escape resides in the signaling pathway, involving the programmed death 1 (PD-1) expressed on the surface of activated T cells and its ligand (PD-L1) expressed by tumor cells. This evidence concerns the gene CD274 and neoplasm.